Belite Bio, Inc
Belite Bio, Inc (BLTE) Revenue
Annual & quarterly revenue history · segment & region breakdown
BLTE · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsBelite Bio, Inc trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from $0.00B in FY2025.
Revenue trend
2025 – 2020 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.00B | +$0.00B | — |
| 2024-12-31 | $0.00B | +$0.00B | — |
| 2023-12-31 | $0.00B | +$0.00B | — |
| 2022-12-31 | $0.00B | +$0.00B | — |
| 2021-12-31 | $0.00B | +$0.00B | — |
| 2020-12-31 | $0.00B | — | — |
Compare revenue vs peers
BiotechnologyCompare BLTE revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Belite Bio, Inc receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Belite Bio, Inc reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Belite Bio, Inc's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
BLTE revenue · 4 questionsBLTE's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from $0.00B in FY2025.
▸ Source: FMP · Belite Bio, Inc SEC filings · GAAP · Belite Bio, Inc SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026